Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Therapeutic Advances in Respiratory Disease

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1753465815602162PMID 26341117PMCID PMC5933657
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• European screening for alpha1‐antitrypsin deficiency in subjects with lung disease

  2017cited by this paper
• Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease.

  2016cited by this paper
• Long-term experience in the treatment of α1-antitrypsin deficiency: 25 years of augmentation therapy

  2015cited by this paper
• Racial Distribution of α1-Antitrypsin Variants among Junior High School Students1

  2015cited by this paper
• Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.

  2015cited by this paper
• Alpha-1 Antitrypsin Augmentation Therapy Corrects Accelerated Neutrophil Apoptosis in Deficient Individuals

  2014cited by this paper
• The Circulating Proteinase Inhibitor α-1 Antitrypsin Regulates Neutrophil Degranulation and Autoimmunity

  2014cited by this paper
• Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid

  2014cited by this paper
• Identification and characterisation of eight novel SERPINA1 Null mutations

  2014cited by this paper
• Appropriateness of Newborn Screening for α1-Antitrypsin Deficiency

  2014cited by this paper
• α1-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population.

  2013cited by this paper
• The Challenge of Detecting Alpha-1 Antitrypsin Deficiency

  2013influential reference
• Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and Italy.

  2013cited by this paper
• The Electrophoretic α1-Globulin Pattern of Serum in α1-Antitrypsin Deficiency

  2013cited by this paper
• Facilitating the laboratory diagnosis of α1-antitrypsin deficiency.

  2013cited by this paper
• Alpha-1 Antitrypsin Deficiency: The European Experience

  2013cited by this paper
• [The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in population of Central Poland--preliminary results from newborn screening].

  2012cited by this paper
• Serum levels and genotype distribution of α1-antitrypsin in the general population

  2012cited by this paper
• Detection Of Patients With Alpha-1 Antitrypsin Deficiency In Germany - Update 2011

  2012cited by this paper
• European screening for α1-antitrypsin deficiency in subjects with lung disease

  2012cited by this paper
• The Prevalence of Alpha-1 Antitrypsin Deficiency Among Patients Found to Have Airflow Obstruction

  2012cited by this paper
• Reference and interpretive ranges for α(1)-antitrypsin quantitation by phenotype in adult and pediatric populations.

  2012cited by this paper
• The prevalence of alpha-1 antitrypsin deficiency in Ireland

  2011cited by this paper
• Impact of a clinical decision support system in an electronic health record to enhance detection of α₁-antitrypsin deficiency.

  2011cited by this paper
• The IDDEA project: a strategy for the detection of alpha-1 antitrypsin deficiency in COPD patients in the primary care setting

  2011cited by this paper
• Cutoff level to detect heterozygous alpha 1 antitrypsin deficiency in Turkish population

  2011cited by this paper
• Knowledge of Alpha-1 Antitrypsin Deficiency Among Internal Medicine House Officers and Respiratory Therapists: Results of a Survey

  2010cited by this paper
• Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres

  2010influential reference
• Diagnostic delay and clinical modifiers in alpha-1 antitrypsin deficiency

  2010cited by this paper
• Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease.

  2010cited by this paper
• Detection of alpha-1 antitrypsin deficiency: a review.

  2009cited by this paper
• Physician Alert Suggesting Alpha-1 Antitrypsin Deficiency Testing in Pulmonary Function Test (PFT) Results

  2009cited by this paper
• Alpha1-antitrypsin deficiency.

  2009cited by this paper
• Evaluation of a new Sebia isoelectrofocusing kit for α1-antitrypsin phenotyping with the Hydrasys® System

  2008cited by this paper
• Alpha-1 antitrypsin Null mutations and severity of emphysema.

  2008cited by this paper
• Patients with Alpha-1 Antitrypsin Deficiency

  2008cited by this paper
• Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development

  2007cited by this paper
• Primary care diagnosis of alpha-1 antitrypsin deficiency: issues and opportunities.

  2007cited by this paper
• Laboratory diagnosis of alpha1-antitrypsin deficiency.

  2007cited by this paper
• Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program.

  2007cited by this paper
• Estimated numbers and prevalence of PI*S and PI*Z alleles of α1-antitrypsin deficiency in European countries

  2006cited by this paper
• Diagnosis of alpha-1-antitrypsin deficiency: An algorithm of quantification, genotyping, and phenotyping.

  2006cited by this paper
• Trends in the diagnosis of symptomatic patients with alpha1-antitrypsin deficiency between 1968 and 2003.

  2005cited by this paper
• Alpha1-antitrypsin deficiency.

  2005cited by this paper
• American Thoracic Society/European Respiratory Society: Standards in Diagnostik und Therapie bei Patienten mit Alpha-1-Antitrypsin-Mangel

  2005cited by this paper
• Results of a case-detection programme for α1-antitrypsin deficiency in COPD patients

  2005cited by this paper
• Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem.

  2005cited by this paper
• Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo.

  2005cited by this paper
• Delay in Diagnosis of α1-Antitrypsin Deficiency: A Continuing Problem

  2005cited by this paper
• Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant.

  2004cited by this paper
• Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology.

  2004cited by this paper
• α1-Antitrypsin deficiency • 4: Molecular pathophysiology

  2004cited by this paper
• Serum Levels of α1-Antitrypsin Predict Phenotypic Expression of the α1-Antitrypsin Gene

  2003cited by this paper
• American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.

  2003cited by this paper
• Serum levels of alpha1-antitrypsin predict phenotypic expression of the alpha1-antitrypsin gene.

  2003cited by this paper
• Profiles of the parents of adolescent CSA perpetrators attending a voluntary outpatient treatment programme in Ireland

  2003cited by this paper
• Change in Lung Function and Morbidity from Chronic Obstructive Pulmonary Disease in 1-Antitrypsin MZ Heterozygotes: A Longitudinal Study of the General Population

  2002cited by this paper
• Screening for α1‐Pi deficiency in patients with lung diseases

  2002cited by this paper
• Human genetics and disease: Serpinopathies and the conformational dementias

  2002cited by this paper
• Detection of Circulating and Endothelial Cell Polymers of Z and Wild Type α1-Antitrypsin by a Monoclonal Antibody*

  2002cited by this paper
• Alpha1-antitrypsin deficiency--a model for conformational diseases.

  2002cited by this paper
• Simple method for alpha1-antitrypsin deficiency screening by use of dried blood spot specimens.

  2000cited by this paper
• Screening for alpha1-Pi deficiency in patients with lung diseases.

  2000cited by this paper
• Alpha 1-antitrypsin deficiency.

  1999cited by this paper
• A national program for detection of alpha 1-antitrypsin deficiency in Italy. Gruppo I.D.A.

  1999cited by this paper
• A national program for detection of α1-antitrypsin deficiency in Italy

  1999cited by this paper
• Alpha 1-antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z.

  1998cited by this paper
• Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.

  1997cited by this paper
• α1-Antitrypsin Deficiency

  1996cited by this paper
• Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey.

  1994cited by this paper
• Molecular Confirmation of α1-Antitrypsin Genotypes in Newborn Dried Blood Specimens

  1993cited by this paper
• Molecular confirmation of alpha 1-antitrypsin genotypes in newborn dried blood specimens.

  1993cited by this paper
• Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.

  1990cited by this paper
• Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening.

  1989cited by this paper
• The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy.

  1989cited by this paper
• Serum alpha 1-antitrypsin deficiency associated with the common S-type (Glu264----Val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion.

  1989cited by this paper
• Neonatal screening for alpha-1-antitrypsin deficiency

  1988cited by this paper
• Alpha 1-antitrypsin Pi-types in 965 COPD patients.

  1986cited by this paper
• Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.

  1981cited by this paper
• Epidemiology of alpha1-antitrypsin deficiency in the Netherlands

  1980cited by this paper
• Alpha 1-antitrypsin screening of 18-year-old men.

  1979cited by this paper
• [Alpha 1-antitrypsin deficiency].

  1978cited by this paper
• Neonatal screening for alpha1-antitrypsin deficiency.

  1978cited by this paper
• Prevalence of of alpha 1-antitrypsin Pi types among newborn infants of different ethnic backgrounds.

  1977cited by this paper
• Relation of protease inhibitor phenotypes to obstructive lung diseases in a community.

  1977cited by this paper
• Amino acid substitution Glu leads to Lys alpha1-antitrypsin PiZ.

  1976cited by this paper
• Distribution of alpha-1-antitrypsin phenotypes in two Dutch population groups

  1976cited by this paper
• Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants.

  1976cited by this paper
• Racial distribution of alpha1-antitrypsin variants among junior high school students.

  1976cited by this paper
• Amino acid substitution Glu→Lys in α1‐antitrypsin PiZ

  1976cited by this paper
• Letter: Diagnosis of alpha1-antitrypsin deficiency.

  1975cited by this paper
• The genetics of α1‐antitrypsin: a family study in England and Scotland

  1975cited by this paper
• Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder.

  1969cited by this paper

• Progression and Augmentation Therapy in PiSZ and PiZZ Alpha-1 Antitrypsin Deficiency: A Longitudinal Functional and Densitometric Study

  2025cites this paper
• Association of AAT/SERPINA1 PI*Z Variant with Gestational Duration and Prevention of Premature Birth in Knockout Mice by AAT-Supplementation

  2025cites this paper
• Detection of nocturnal hypoxaemia leading to a diagnosis of COPD and PiMZ alpha-1 antitrypsin deficiency

  2025cites this paper
• Patient experience of alpha-1 antitrypsin deficiency-associated liver disease: a qualitative study

  2025cites this paper
• Patient-centered assessment of treatment for alpha-1 antitrypsin deficiency: literature review to identify concepts and measures for people with alpha1-antitrypsin deficiency

  2025cites this paper
• Advancing the understanding and treatment of lung pathologies associated with alpha 1 antitrypsin deficiency

  2025cites this paper
• Alpha-1 Antitrypsin Deficiency Screening Using Serum Protein Electrophoresis

  2025cites this paper
• Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit

  2024cites this paper
• Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives

  2024cites this paper
• Haplotype-aware detection of SERPINA1 variants by nanopore sequencing.

  2024cites this paper
• Improving Detection of Alpha-1 Antitrypsin Deficiency: Role of the Allergist.

  2023cites this paper
• High Conjugated Bilirubin Levels in a Term Infant.

  2023cites this paper
• Small airways disease in patients with alpha-1 antitrypsin deficiency.

  2023cites this paper
• Increased Prevalence of Alpha-1-Antitrypsin Deficiency in Patients with Biliary Tract Cancer and Its Associated Clinicopathological Features

  2023cites this paper
• Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence

  2023cites this paper
• Optimizing the screening of alpha-1 antitrypsin deficiency using serum protein electrophoresis

  2022cites this paper
• New variants of alpha-1-antitrypsin: structural simulations and clinical expression

  2022cites this paper
• The Prevalence of Liver Diseases among Chronic Obstructive Pulmonary Disease Patients: Statistics from Riyadh, Saudi Arabia

  2021cites this paper
• Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil

  2021cites this paper
• Challenges Faced by Rural Primary Care Providers When Caring for COPD Patients in the Western United States.

  2021cites this paper
• Intermediate Alpha-1 Antitrypsin Deficiency Can Play a Role in Pulmonary Exacerbation?

  2021cites this paper
• The spectrum of clinical sequelae associated with alpha-1 antitrypsin deficiency

  2021cites this paper
• Improving the Lives of Patients with Alpha-1 Antitrypsin Deficiency

  2020cites this paper
• Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US

  2020cites this paper
• Prevalence of α1-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review

  2020cites this paper
• New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency

  2020influential citation
• Knowledge of Rare Respiratory Diseases among Paediatricians and Medical School Students

  2020cites this paper
• Reduced 25(OH) Vitamin D Association with Lower Alpha-1-Antitrypsin Blood Levels in Type 2 Diabetic Patients

  2020cites this paper
• The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes

  2020cites this paper
• New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin De fi ciency

  2020influential citation
• New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin De fi ciency

  2020influential citation
• COPD_A_263297 2389..2397

  2020cites this paper
• Genetic studies of multifactorial diseases in the concept of personalized medicine

  2019cites this paper
• A Novel Approach to Screening for Alpha-1 Antitrypsin Deficiency: Inpatient Testing at a Teaching Institution.

  2018cites this paper
• Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications

  2018cites this paper
• Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC

  2018cites this paper
• Alpha-1 antitrypsin deficiency: outstanding questions and future directions

  2018cites this paper
• Advances in managing COPD related to α1‐antitrypsin deficiency: An under‐recognized genetic disorder

  2018influential citation
• Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency

  2018cites this paper
• Abnormal Liver Enzymes

  2018cites this paper
• Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients

  2017cites this paper
• COPD: JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

  2017cites this paper
• Mesenchymal stem/stromal cells engineered to express the protease inhibitor alpha-1 antitrypsin for the treatment of inflammatory lung diseases

  2017cites this paper
• Clinical Management and Treatment of Lung Disease

  2017cites this paper
• Chapter 9 – Clinical Diagnosis

  2017cites this paper
• The prevalence of PI∗S and PI∗Z SERPINA1 alleles in healthy individuals and COPD patients in Saudi Arabia

  2017cites this paper
• Übersicht COPD

  2017cites this paper
• Alpha-1-Antitrypsin Deficiency: Disease Management and Learning from Studies

  2017cites this paper
• State-of-the-art testing for alpha-1 antitrypsin deficiency.

  2017cites this paper
• Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis

  2017cites this paper
• Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).

  2017cites this paper
• The Allergist's Role in Detection of Severe Alpha-1 Antitrypsin Deficiency.

  2017cites this paper
• The prevalence of diagnosed α1-antitrypsin deficiency and its comorbidities: results from a large population-based database

  2017cites this paper
• Practical Methods for Assessing Emphysema Severity Based on Estimation of Linear Mean Intercept (Lm) in the Context of Animal Models of Alpha-1 Antitrypsin Deficiency.

  2017cites this paper
• Association of alpha-1 antitrypsin level and lung function in patients with chronic obstructive pulmonary disease

  2017cites this paper
• Understanding alpha-1 antitrypsin deficiency: A review with an allergist's outlook.

  2017cites this paper
• Alpha-1 Antitrypsin Deficiency: Current Perspective from Genetics to Diagnosis and Therapeutic Approaches.

  2017cites this paper
• Management of chronic airway diseases: What can we learn from real-life data?

  2017cites this paper
• Biochemical comparison of four commercially available human α1-proteinase inhibitors for treatment of α1-antitrypsin deficiency.

  2017cites this paper
• Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015

  2016cites this paper
• Diagnosis of alpha-1 antitrypsin deficiency: a population-based study

  2016cites this paper
• Difficultés liées au diagnostic de déficit en α1-antitrypsine en soins de première ligne

  2016cites this paper
• Challenge of α1-antitrypsin deficiency diagnosis in primary care.

  2016cites this paper
• Optimizing the glycosylation of recombinant proteins

  2016cites this paper
• A Library of Rare α1-Antitrypsin (AAT) Variant Phenotypes to Aid in the Diagnosis of AAT Deficiency.

  2016cites this paper
• Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency

  2016cites this paper
• Diagnosing alpha-1 antitrypsin deficiency: does it prevent or improve the course of COPD?

  2016cites this paper
• Genetic variants in adult liver diseases

  2015cites this paper